
Cholesterol trafficking disruption targets TP53-mutant cancers
<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxNM1VQUndBd1V6dUtOVE1HcnNvZ3VPamc5eUZrS2JKRXN6VlRhTlNZby1sQjhuYVNybXpCaVhucjE3eThPNnRQbjR1T3FXS0pnenloVkNmOW9Dc3VkRy1TakhxVlN3Z21YUFhiM3Jxb0UwNER0eUdyazZINVVHWW15cVJIQmlNd0w3MEVZaVdrQy00dGlYX2FFRDlRb295R3dyQTM2Z3JXZ0g4d1JTTy1MMQ?oc=5" target="_blank">Cholesterol trafficking disruption targets TP53-mutant cancers</a>&nbsp;&nbsp;<font color="#6f6f6f">Drug Target Review</font>
